MENU
BOLD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Boundless Bio (BOLD) Ownership - Who owns Boundless Bio?
Boundless Bio Inc is a clinical-stage oncology company... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
9880 Campus Point Drive
Phone
+1 858 766-9912
Employees
72
Web
https://www.boundlessbio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
25.52M
P/E Ratio
0.16
Total Cash
127.15M
Projected Growth
N/A
Total Debt
49.51M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
5.68
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
BOLD
Capitalization
25.5M
P/E Ratio
0.16
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
127M
Total Cash/Share
5.68
Total Debt
49.5M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
123M
P/B Ratio
0.21
Cash Flow
N/A
Earnings
-2.48
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2K
Current Ratio
14.08
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-70.2M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-35.03
Shares Held By Institutions
422M
Shares Outstanding - Current
22.4M
Total Liabilities
56.8M
Total Volume MTD
N/A
Value
1
Gain YTD
-60.690
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. BOLD showed earnings on August 05, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
a developer of gene therapy products for patients with serious rare diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
9880 Campus Point Drive
Phone
+1 858 766-9912
Employees
72
Web
https://www.boundlessbio.com